Resistance arteries undergo structural changes (vascular remodelling) in hypertension. These changes involve media thickening, reduced lumen diameter and consequent increased media:lumen ratio. Cellular processes underlying these events include altered vascular smooth muscle cell (VSMC) growth, migration, differentiation and increased extracellular matrix abundance. Another factor contributing to remodelling is inflammation, associated with macrophage infiltration, fibrosis and increased expression of redox-sensitive pro-inflammatory genes. Among the factors involved in arterial remodelling, angiotensin (Ang) II appears to be one of the most important. Ang II, a multifunctional peptide with pleiotropic actions, modulates vasomotor tone, cel...
International audienceAngiotensin II is a potent growth factor involved in arterial wall homeostasis...
International audienceAngiotensin II is a potent growth factor involved in arterial wall homeostasis...
Until recently, the signaling events elicited in vascular smooth muscle cells by angiotensin II (Ang...
Resistance arteries undergo structural changes (vascular remodelling) in hypertension. These changes...
A major hemodynamic abnormality in hypertension is increased peripheral resistance due to changes in...
Summary<p></p> 1. Hypertension is associated with structural alterations of resistanc...
Vascular injury, characterized by endothelial dysfunction, structural remodelling, inflammation and ...
Vascular injury, characterized by endothelial dysfunction, structural remodelling, inflammation and ...
Hypertension is associated with vascular changes characterised by remodelling, endothelial dysfuncti...
Hypertension is associated with vascular changes characterised by remodelling, endothelial dysfuncti...
Diseases such as hypertension, atherosclerosis, hyperlipidemia, and diabetes are associated with vas...
Angiotensin II (Ang II) is a pleiotropic hormone that influences the function of many cell types and...
Diseases such as hypertension, atherosclerosis and diabetes are associated with vascular functional ...
Diseases such as hypertension, atherosclerosis, hyperlipidemia, and diabetes are associated with va...
Purpose of review: Transmission of external signals from the cell surface to the internal cellular e...
International audienceAngiotensin II is a potent growth factor involved in arterial wall homeostasis...
International audienceAngiotensin II is a potent growth factor involved in arterial wall homeostasis...
Until recently, the signaling events elicited in vascular smooth muscle cells by angiotensin II (Ang...
Resistance arteries undergo structural changes (vascular remodelling) in hypertension. These changes...
A major hemodynamic abnormality in hypertension is increased peripheral resistance due to changes in...
Summary<p></p> 1. Hypertension is associated with structural alterations of resistanc...
Vascular injury, characterized by endothelial dysfunction, structural remodelling, inflammation and ...
Vascular injury, characterized by endothelial dysfunction, structural remodelling, inflammation and ...
Hypertension is associated with vascular changes characterised by remodelling, endothelial dysfuncti...
Hypertension is associated with vascular changes characterised by remodelling, endothelial dysfuncti...
Diseases such as hypertension, atherosclerosis, hyperlipidemia, and diabetes are associated with vas...
Angiotensin II (Ang II) is a pleiotropic hormone that influences the function of many cell types and...
Diseases such as hypertension, atherosclerosis and diabetes are associated with vascular functional ...
Diseases such as hypertension, atherosclerosis, hyperlipidemia, and diabetes are associated with va...
Purpose of review: Transmission of external signals from the cell surface to the internal cellular e...
International audienceAngiotensin II is a potent growth factor involved in arterial wall homeostasis...
International audienceAngiotensin II is a potent growth factor involved in arterial wall homeostasis...
Until recently, the signaling events elicited in vascular smooth muscle cells by angiotensin II (Ang...